Filed: 11/14/2022ACC: 0000919574-22-006635
📋 What this filing means
CAXTON CORP filed this quarterly 13F‑HR report disclosing 17 equity positions with a total reported market value of $53.2K. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
17
Positions
$53.2K
Total AUM (reported)
18.89M
Total Shares
Allocation by class
COM$22.6K42.5%
UNITS$11.3K21.3%
COM NEW$8.0K15.0%
TR UNIT$5.7K10.7%
S&P OILGAS EXP$2.2K4.1%
COMMON STOCK$1.4K2.7%
ALERIAN MLP$1.1K2.0%
Portfolio Concentration
Top 3$31.4K59.1%
4–10$19.9K37.4%
11–25$1.8K3.5%
Top 3 weight
59.1%
Top 10 weight
96.5%
Voting Authority Distribution
Total shares with voting rights: 18.89M
Sole
Full voting authority
18.89M
shares
% of voting shares100.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole17
Shared0
Other0
Dominant voting typeSole · 100.0% of voting shares
Institutional Holdings17
Rows:
UNITED STS OIL FD LP
SOLEShares173.50K
TypeSH
Market value$11.3K
21.30%
Sole
173.50K
Shared
0.00
None
0.00
SAVARA INC
SOLEShares6.90M
TypeSH
Market value$10.7K
20.10%
Sole
6.90M
Shared
0.00
None
0.00
XERIS BIOPHARMA HOLDINGS INC
SOLEShares6.04M
TypeSH
Market value$9.4K
17.71%
Sole
6.04M
Shared
0.00
None
0.00
SPDR S&P 500 ETF TR
SOLEShares15.95K
TypeSH
Market value$5.7K
10.71%
Sole
15.95K
Shared
0.00
None
0.00
SCYNEXIS INC
SOLEShares1.72M
TypeSH
Market value$4.1K
7.78%
Sole
1.72M
Shared
0.00
None
0.00
REZOLUTE INC
SOLEShares1.40M
TypeSH
Market value$3.8K
7.23%
Sole
1.40M
Shared
0.00
None
0.00
SPDR SER TR
SOLEShares17.50K
TypeSH
Market value$2.2K
4.10%
Sole
17.50K
Shared
0.00
None
0.00
MOLECULAR TEMPLATES INC
SOLEShares2.05M
TypeSH
Market value$1.5K
2.89%
Sole
2.05M
Shared
0.00
None
0.00
ARCELLX INC
SOLEShares76.19K
TypeSH
Market value$1.4K
2.69%
Sole
76.19K
Shared
0.00
None
0.00
ALPS ETF TR
SOLEShares29.50K
TypeSH
Market value$1.1K
2.03%
Sole
29.50K
Shared
0.00
None
0.00
EIGER BIOPHARMACEUTICALS INC
SOLEShares116.88K
TypeSH
Market value$880.00
1.65%
Sole
116.88K
Shared
0.00
None
0.00
VECTIVBIO HLDG AG
SOLEShares140.86K
TypeSH
Market value$845.00
1.59%
Sole
140.86K
Shared
0.00
None
0.00
ELEVATION ONCOLOGY INC
SOLEShares68.30K
TypeSH
Market value$77.00
0.14%
Sole
68.30K
Shared
0.00
None
0.00
FRAZIER LIFESCIENCES ACQU CO
SOLEShares21.33K
TypeSH
Market value$17.00
0.03%
Sole
21.33K
Shared
0.00
None
0.00
LUX HEALTH TECH ACQUISITION
SOLEShares66.67K
TypeSH
Market value$9.00
0.02%
Sole
66.67K
Shared
0.00
None
0.00
BRIDGETOWN HOLDINGS LTD
SOLEShares39.77K
TypeSH
Market value$5.00
<0.01%
Sole
39.77K
Shared
0.00
None
0.00
PRIMAVERA CAPITAL ACQUIST CO
SOLEShares12K
TypeSH
Market value$2.00
<0.01%
Sole
12K
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
UNITED STS OIL FD LPSOLE | UNITS | 173.50K | SH | $11.3K 21.30% | 173.50K | 0.00 | 0.00 |
SAVARA INCSOLE | COM | 6.90M | SH | $10.7K 20.10% | 6.90M | 0.00 | 0.00 |
XERIS BIOPHARMA HOLDINGS INCSOLE | COM | 6.04M | SH | $9.4K 17.71% | 6.04M | 0.00 | 0.00 |
SPDR S&P 500 ETF TRSOLE | TR UNIT | 15.95K | SH | $5.7K 10.71% | 15.95K | 0.00 | 0.00 |
SCYNEXIS INCSOLE | COM NEW | 1.72M | SH | $4.1K 7.78% | 1.72M | 0.00 | 0.00 |
REZOLUTE INCSOLE | COM NEW | 1.40M | SH | $3.8K 7.23% | 1.40M | 0.00 | 0.00 |
SPDR SER TRSOLE | S&P OILGAS EXP | 17.50K | SH | $2.2K 4.10% | 17.50K | 0.00 | 0.00 |
MOLECULAR TEMPLATES INCSOLE | COM | 2.05M | SH | $1.5K 2.89% | 2.05M | 0.00 | 0.00 |
ARCELLX INCSOLE | COMMON STOCK | 76.19K | SH | $1.4K 2.69% | 76.19K | 0.00 | 0.00 |
ALPS ETF TRSOLE | ALERIAN MLP | 29.50K | SH | $1.1K 2.03% | 29.50K | 0.00 | 0.00 |
EIGER BIOPHARMACEUTICALS INCSOLE | COM | 116.88K | SH | $880.00 1.65% | 116.88K | 0.00 | 0.00 |
VECTIVBIO HLDG AGSOLE | ORD SHS | 140.86K | SH | $845.00 1.59% | 140.86K | 0.00 | 0.00 |
ELEVATION ONCOLOGY INCSOLE | COM | 68.30K | SH | $77.00 0.14% | 68.30K | 0.00 | 0.00 |
FRAZIER LIFESCIENCES ACQU COSOLE | *W EXP 11/30/202 | 21.33K | SH | $17.00 0.03% | 21.33K | 0.00 | 0.00 |
LUX HEALTH TECH ACQUISITIONSOLE | *W EXP 11/30/202 | 66.67K | SH | $9.00 0.02% | 66.67K | 0.00 | 0.00 |
BRIDGETOWN HOLDINGS LTDSOLE | *W EXP 09/30/202 | 39.77K | SH | $5.00 <0.01% | 39.77K | 0.00 | 0.00 |
PRIMAVERA CAPITAL ACQUIST COSOLE | *W EXP 01/19/202 | 12K | SH | $2.00 <0.01% | 12K | 0.00 | 0.00 |